Serum leptin concentrations in normal humans have been reported to cor
relate with the body mass index (BMI) as well as with the body fat mas
s. In this study, we measured serum leptin concentrations in 107 patie
nts on hemodialysis, 30 of whom had diabetes mellitus as the cause, an
d examined the clinical significance. Furthermore, we evaluated the ef
fects of high-flux dialysis membranes on serum leptin levels. Serum le
ptin concentrations had a linear correlation with BMI as well as with
the percentage of body fat in patients on hemodialysis. The serum lept
in concentrations showed a positive correlation with the serum concent
rations of total cholesterol, low-density lipoprotein cholesterol, and
triglyceride, the body weight, the BMI, and the percentage of body fa
t. The serum leptin levels were not different between the diabetic and
the nondiabetic groups. The serum leptin levels in the nondiabetic gr
oup were nearly fourfold higher in wc,men than in men. We investigated
the differences in the rate of reduction in serum leptin after dialys
is with polysulfone membrane dialyzers (PS-N and PS-UW) in comparison
with a cellulose membrane dialyzer (AM-SD), and as a result, we found
that the polysulfone membrane dialyzers removed serum leptin, while th
e cellulose membrane dialyzer did not. We conclude that in patients on
hemodialysis, the serum leptin concentration is a valuable clinical m
arker of the body fat content and may also contribute to the evaluatio
n of hyperlipidemia.